– Phase 1b Safety and Efficacy Data for Rezpegaldesleukin in Moderate to Severe Atopic Dermatitis to be Presented in Late-Breaking Oral Presentation –
SAN FRANCISCO, Oct. 2, 2023 /PRNewswire/ .
Brazil s Mato Gosso launches call for US$2 3bn railway bnamericas.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnamericas.com Daily Mail and Mail on Sunday newspapers.